DWA
CELG

Dorsey Wright & Associates’s Celgene Corp CELG Stock Holding History

Dorsey Wright & Associates’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-10,504
Closed -$1.21M – 134
2015
Q1 		$1.21M Buy
+10,504
New +$1.26M 0.55% 48

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dorsey Wright & Associates's CELG Position: Q2 2015 in Review

Dorsey Wright & Associates sold out of Celgene Corp (CELG) in Q2 2015, closing a stake of 10,504 shares — an estimated $1.21M sold.

Dorsey Wright & Associates first reported a position in CELG in Q1 2015 and held it in 1 quarter. The position peaked at $1.21M in Q1 2015. 1,201 funds tracked by Wall St. Rank hold CELG as of Q2 2015.

  • Dorsey Wright & Associates reported no remaining Celgene Corp position as of Q2 2015 after selling out during the quarter.
  • Dorsey Wright & Associates sold 10,504 Celgene Corp shares in Q2 2015, an estimated $1.21M.
  • Dorsey Wright & Associates first reported a position in Celgene Corp in Q1 2015 and held it in 1 quarter.
  • Dorsey Wright & Associates's Celgene Corp position peaked at $1.21M in Q1 2015.
  • 1,201 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2015.

Based on Dorsey Wright & Associates's 13F filing for Q2 2015, filed 23 Jul 2015.